Last reviewed · How we verify
Rifaximin 200 MG
Rifaximin 200 MG is a Small molecule drug developed by Zagazig University. It is currently FDA-approved.
At a glance
| Generic name | Rifaximin 200 MG |
|---|---|
| Sponsor | Zagazig University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea (PHASE4)
- Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers (PHASE1)
- The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin (NA)
- Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver Cirrhosis (PHASE3)
- Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia (PHASE2)
- Effect of Fecal Microbiota Transfer on Progression of Parkinson Disease (PHASE2)
- Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction (NA)
- Efficacy and Safety of Rifaximin With NAC in IBS-D (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rifaximin 200 MG CI brief — competitive landscape report
- Rifaximin 200 MG updates RSS · CI watch RSS
- Zagazig University portfolio CI
Frequently asked questions about Rifaximin 200 MG
What is Rifaximin 200 MG?
Rifaximin 200 MG is a Small molecule drug developed by Zagazig University.
Who makes Rifaximin 200 MG?
Rifaximin 200 MG is developed and marketed by Zagazig University (see full Zagazig University pipeline at /company/zagazig-university).
What development phase is Rifaximin 200 MG in?
Rifaximin 200 MG is FDA-approved (marketed).
Related
- Manufacturer: Zagazig University — full pipeline
- Compare: Rifaximin 200 MG vs similar drugs
- Pricing: Rifaximin 200 MG cost, discount & access